Published in Br J Cancer on October 01, 1998
Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics (2008) 2.09
Proteomic based identification of manganese superoxide dismutase 2 (SOD2) as a metastasis marker for oral squamous cell carcinoma. Cancer Genomics Proteomics (2008) 1.34
Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med (2008) 1.11
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer. Urol Oncol (2011) 0.99
Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma. BMC Cancer (2010) 0.98
Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth. Clin Exp Metastasis (2006) 0.95
Nuclear oxidative damage correlates with poor survival in colorectal cancer. Br J Cancer (2008) 0.92
Mutations in the SOD2 promoter reveal a molecular basis for an activating protein 2-dependent dysregulation of manganese superoxide dismutase expression in cancer cells. Mol Cancer Res (2008) 0.92
Alteration of extracellular superoxide dismutase expression is associated with an aggressive phenotype of oral squamous-cell carcinoma. Exp Ther Med (2010) 0.82
Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis. Mol Cell Proteomics (2011) 0.82
The role of manganese superoxide dismutase in skin cancer. Enzyme Res (2011) 0.81
Expression and potential role of apolipoprotein D on the death-survival balance of human colorectal cancer cells under oxidative stress conditions. Int J Colorectal Dis (2013) 0.80
Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma. Br J Cancer (2000) 0.79
Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cells. Free Radic Biol Med (2008) 0.79
Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial. Evid Based Complement Alternat Med (2012) 0.78
Chemopreventive efficacy of ginger (Zingiber officinale) in ethionine induced rat hepatocarcinogenesis. Afr J Tradit Complement Altern Med (2008) 0.78
Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial. Evid Based Complement Alternat Med (2011) 0.77
Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. Br J Cancer (2000) 0.77
Characterization of intracellular superoxide dismutase alterations in premalignant and malignant lesions of the oral cavity: correlation with lymph node metastasis. J Cancer Res Clin Oncol (2009) 0.77
Effect of Uncaria tomentosa Extract on Apoptosis Triggered by Oxaliplatin Exposure on HT29 Cells. Evid Based Complement Alternat Med (2014) 0.77
Manganese superoxide dismutase in cancer prevention. Antioxid Redox Signal (2013) 0.77
Manganese superoxide dismutase promotes interaction of actin, S100A4 and Talin, and enhances rat gastric tumor cell invasion. J Clin Biochem Nutr (2015) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 43.83
Superoxide dismutases. Annu Rev Biochem (1975) 8.00
The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg (1954) 6.74
Free-radical mechanisms in tissue injury. Biochem J (1984) 4.70
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology (1986) 3.70
Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science (1988) 3.60
Role of superoxide dismutase in cancer: a review. Cancer Res (1979) 3.34
Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell (1989) 3.29
Superoxide dismutases. Prog Nucleic Acid Res Mol Biol (1991) 2.65
Mechanisms of cell injury by activated oxygen species. Lab Invest (1990) 1.69
Antioxidant enzyme levels in cancer. Histol Histopathol (1997) 1.60
Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem (1993) 1.58
Oxidative mechanisms in carcinogenesis. Br Med Bull (1993) 1.54
Mechanisms of cell injury by activated oxygen species. Environ Health Perspect (1994) 1.42
Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study. Cancer (1992) 1.26
Prognostic factors in colorectal cancer. Br J Surg (1992) 1.25
Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Radic Biol Med (1990) 1.17
Redox regulation of manganese superoxide dismutase. Am J Physiol (1996) 1.14
The level of MnSOD is directly correlated with grade of brain tumours of neuroepithelial origin. Br J Cancer (1996) 0.99
A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood (1993) 0.96
Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res (1990) 0.95
Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res (1994) 0.95
Colon cancer overview. Cancer (1992) 0.95
Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy. Cancer Res (1995) 0.94
Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res (1996) 0.93
Staging of cancer of the colon and rectum. Cancer (1992) 0.91
Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch (1994) 0.89
Significance of superoxide dismutase (SOD) in human colorectal cancer tissue: correlation with malignant intensity. J Gastroenterol (1995) 0.87
Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy. Cancer Res (1990) 0.86
Neoplasia-related changes of two copper (Cu)/zinc (Zn) proteins in the human colon. Free Radic Biol Med (1990) 0.86
Current chemotherapeutic possibilities in the treatment of colorectal cancer. Eur J Cancer (1995) 0.86
Role of superoxide dismutase in modification of radiation injury. Br J Cancer Suppl (1987) 0.84
Acute-phase induction of manganese superoxide dismutase in intestinal epithelial cell lines. Gastroenterology (1992) 0.84
Gastric mucosal superoxide dismutases in Helicobacter pylori infection. Gut (1996) 0.81
Radiation and chemically induced transformation: free radicals, antioxidants and cancer. Br J Cancer Suppl (1987) 0.81
Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma. Melanoma Res (1995) 0.80
Expression of cytokines, TNF-alpha and IL-1 alpha, in MAM acetate and 1-hydroxyanthraquinone-induced colon carcinogenesis of rats. Carcinogenesis (1994) 0.79
Oxygen free radical activity in experimental colonic carcinoma. Br J Surg (1994) 0.79
Colorectal carcinoma: an update. Neth J Med (1991) 0.78
Removing oxygen-derived free radicals delays hepatic metastases and prolongs survival in colonic cancer. A study in the rat. Oncology (1992) 0.77
Free radical biology: a paradox in cancer research. J Natl Cancer Inst (1990) 0.77
Growth-related expression of ribosomal protein genes in Saccharomyces cerevisiae. Mol Gen Genet (1993) 14.93
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol (2001) 5.28
Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med (1996) 4.11
Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med (1994) 4.00
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology (1996) 3.54
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem (1993) 3.41
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
[Autopsy are a useful quality instrument because of unexpected clinical relevant findings and the answering of clinical questions; a retrospective study]. Ned Tijdschr Geneeskd (2003) 3.17
Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol (1995) 3.06
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol (2001) 2.71
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol (1999) 2.57
Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet (2001) 2.35
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. Gastroenterology (1994) 2.22
No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol (2001) 2.20
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut (2008) 2.06
[Entering of patients in clinical-oncological trials: why not exclusive exclusion when inclusion is out of the question?]. Ned Tijdschr Geneeskd (1995) 2.03
Cosmesis and body image after laparoscopic-assisted and open ileocolic resection for Crohn's disease. Surg Endosc (1998) 1.93
Long term serological surveillance after treatment of Helicobacter pylori infection. Gut (1991) 1.90
Identification of virilizing adrenal tumors in hirsute women. N Engl J Med (1994) 1.90
Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg (1996) 1.90
Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut (1997) 1.88
Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer (2001) 1.88
Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet (1987) 1.83
Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol (2001) 1.83
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol (1993) 1.79
Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion (1997) 1.75
Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74
Cholesterol crystal embolization in the Netherlands. Arch Intern Med (1996) 1.74
Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg (1988) 1.72
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer (1996) 1.71
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood (2000) 1.69
The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol (1991) 1.67
Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol (1993) 1.66
The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med (1990) 1.65
DNA ploidy and survival in breast cancer patients. Cytometry (1987) 1.65
CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol (2001) 1.63
The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol (1997) 1.63
Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining. Am J Pathol (1991) 1.63
Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood (1998) 1.63
Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther (1998) 1.61
Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta (1983) 1.61
Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology (1996) 1.59
Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.59
Eight novel inactivating germ line mutations at the APC gene identified by denaturing gradient gel electrophoresis. Genomics (1992) 1.59
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer (1994) 1.59
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene (1991) 1.56
Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study. Gastroenterology (1996) 1.55
Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. J Pathol (1992) 1.55
Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut (2003) 1.55
Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res (1989) 1.55
Satiety effects of cholecystokinin in humans. Gastroenterology (1994) 1.55
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol (2000) 1.54
Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res (1985) 1.53
An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach. Neth J Med (2011) 1.53
Nonulcer dyspepsia in a Dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med (1995) 1.52
Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease. J Gastroenterol Hepatol (1995) 1.52
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50
Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg (1989) 1.49
Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys (1998) 1.49
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer (1998) 1.49
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48
Serum gastrin and mucosal somatostatin in Helicobacter pylori-associated gastritis. Scand J Gastroenterol (1995) 1.47
Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol (1992) 1.46
Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Am J Gastroenterol (1997) 1.46
Clinical presentation of Helicobacter pylori-positive and -negative functional dyspepsia. J Gastroenterol Hepatol (2000) 1.46
Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol (1999) 1.44
Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum Mutat (1997) 1.44
Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet (1996) 1.43
Gall bladder emptying in severe idiopathic constipation. Gut (1999) 1.43
Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? Aliment Pharmacol Ther (2002) 1.43
Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol (1996) 1.42
The benefits of participation in clinical trials. Eur J Surg Oncol (1996) 1.41
The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer. Eur J Surg Oncol (1999) 1.40
Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer (2005) 1.40
Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer (1997) 1.40